PUBLISHED ARTICLES (Refereed journals)
Lamiraud K, Vranceanu R (2026). Do patients value the service provided by physicians who overbill? A willingness-to-pay study using French survey data. Health Economics. Forthcoming.
Lamiraud K, Le Guern M, Rockinger M, Sevilla-Dedieu C (2026). Preference for gender concordant GP and medical deserts. Review of Economics of the Household. Published online May 18th 2026.
Lamiraud K, Vranceanu R (2025). A Two-sector Model of Healthcare Provision with Directed Search. Theory and Decision 99: 877-907.
Lamiraud K, Patris J, Vranceanu R (2024). Can attentional nudges improve efficiency of bilateral multi-attribute negotiations? Journal of Behavioral and Experimental Economics 110.
Besancenot D, Lamiraud K, Vranceanu R (2023). A Model for Dual Healthcare Market with Congestion Differentiation. Journal of Economics & Management Strategy 32:400–423.
Baker L, Lamiraud K. (2022). Adoption of Hospital Diagnosis-Related Group Financing in Switzerland and the Availability of CT Scanners. Health Economics. 31:2537–2557.
Besancenot D, Lamiraud K, Vranceanu R (2021). Balance Billing as an Adherence to Treatment Signalling Device. Journal of Institutional and Theoretical Economics 177: 1-32 also available here
Lamiraud K, Stadelmann P. (2020). Switching Costs in Competitive Health Insurance Markets: The Role of Insurers’ Pricing Strategies. Health Economics 29:992-1012.
Lamiraud K, Vranceanu R (2018). Group gender composition and economic decision-making: Evidence from the Kallystée business game. Journal of Economic Behavior & Organization 145: 294-305.
Lamiraud K, Lhuillery S (2016). Endogenous Technology Adoption and Medical Costs. Health Economics 25: 1123-1147. Also available here
Lamiraud K, Oxoby R, Donaldson C (2016). Incremental willingness to pay: a theoretical and empirical exposition. Theory and Decision 80:101-123. Also available here
Nicod E, Stringhini S, Marques-Vidal P, Paccaud F, Waeber G, Lamiraud K, Vollenweider P, Bochud M (2014). Association of education and receiving social transfers with allostatic load in the Swiss population-based CoLaus study. Preventive Medicine 63: 63-71. Also available here
Gossec L, Berenbaum F, Chauvin P, Lamiraud K, Russo-Marie F, Joubert JM, Saraux A (2014). Reporting of patient-perceived impact of rheumatoid arthritis and spondyloarthritis over 10 years: a systematic literature review. Rheumatology 53 (7): 1274- 1281. Also available here
Dormont B, Geoffard PY, Lamiraud K (2012). Assurance maladie en Suisse :les assurances supplémentaires nuisent-elles à la concurrence sur l’assurance de base ? Economie et Statistiques 455-456: 71-87. Also available here
Lamiraud K, Moatti JP, Raffi F, Carrieri P, Protopopescu C, Michelet C, Schneider L, Collin F, Leport C, Spire B (2012). Adherence to and effectiveness of Highly Active Antiretroviral Treatment for HIV infection: assessing the bidirectional relationship. Medical Care 50: 410-418. Also available here
Saffer H, Lamiraud K (2012). The effect of hours of work on social interaction. Review of Economics of the Household 10: 237-258 (also available as NBER Working paper #13743 and here)
Lamiraud K, Holly A, Burnand B, Juillerat P, Wietlisbach V, Froehlich F, Gonvers JJ, Vader JP (2010). The effect of non-medical factors on variations in the performance of colonoscopy among different health care settings. Medical Care 48(2): 101-109.
Lamiraud K, Von Bremen K, Donaldson C (2009). The impact of information on patient preferences in different delivery patterns: prescription versus OTC. Health Policy 93 (2-3): 102–110.
Dormont B, Geoffard PY, Lamiraud K (2009). The influence of supplementary health insurance on switching behaviour: evidence from Swiss data. Health Economics 18(11): 1339-1356.
Frank RG, Lamiraud K (2009). Choice, Price competition and Complexity in Markets for Health Insurance. Journal of Economic Behavior and Organization 71(2): 550-562. (also available as NBER Working paper #13817, February 2008)
Lamiraud K, Geoffard PY (2007). Therapeutic non adherence: a rational behaviour revealing patient preferences? Health Economics 16 (11):1185-1204. This article was awarded the “Best Paper” prize of papers published in Health Economics in 2006-2007.
Lamiraud K, Moatti JP (2006). Economic implications of non-adherence to HAART in HIV patients. Expert Opinion on Pharmacotherapy 7 (2): 135-143.
CHAPTERS IN BOOKS (Refereed publications)
Lamiraud K (2014). Switching Costs in Competitive Health Insurance Markets. In: Anthony J. Culyer (ed.), Encyclopedia of Health Economics, Vol 3. San Diego: Elsevier; 2014. pp. 375-381.
Moschetti K, Lamiraud K, Holly A, O’Donnell O (2011). Does Poor Childhood Help Explain Health Care Utilisation and Payments in Middle and Old Age? In: The Individual and the Welfare State. Life Histories in Europe, Axel Börsch-Supan, Martina Brandt, Karsten Hank and Mathis Schröder (eds). Springer: Heidelberg.
Lamiraud K (2011). Le rôle des consommateurs dans la concurrence des systèmes d'assurance santé: l’exemple de la Suisse. In La régulation des secteurs de la Santé. Thèmes et commentaires. Droit et Economie de la Régulation, MA Frison-Roche (ed). Presses de Sciences Po et Dalloz: Paris.
Holly A, Lamiraud K, Moschetti K, Yalcin T (2008). Changes in health out-of-pocket (OOP) payments and health care utilization in the early post retirement period. In Health, Ageing and Retirement in Europe (2004-2007) – Starting the longitudinal dimension, Börsch-Supan A, Brugiavini A, Jürges H, Kapteyn A, Mackenbach J, Siegrist J, Weber G (eds). Mannheim: MEA.
Scheil-Adlung X, Booysen F, Lamiraud K, Reynaud E, Juetting J, Asfaw A, Xu K, Carrin G, Chatterji S, Evans D, James C, Muchiri S (2006). What is the impact of social health protection on access to health care, health expenditure and impoverishment ? A comparative analysis of three African countries. World Health Organization EIP/HSP/DP.06. Available at SSRN: http://ssrn.com/abstract=916703
Lamiraud K, Booysen F, Scheil-Adlung X (2005). The Impact of Social Health Protection on Access to Health Care, Health Expenditure and Impoverishment: A Case Study of South Africa. International Labour Office, Department of social security, Extension of Social Security Paper Series 23. Available at SSRN: http://ssrn.com/abstract=822704
Holly A, Lamiraud K, Chevrou-Severac H, Yalcin T (2005). Out-of-pocket payments for health care expenditures. In Health, Ageing and Retirement in Europe – First results from the Survey of Health, Ageing and Retirement in Europe, Börsch-Supan A, Brugiavini A, Jürges H, Mackenbach J, Siegrist J (eds). Mannheim: MEA.
WORKING PAPERS (Unpublished papers)
Lamiraud K, Oxoby RJ, Donaldson C (2016). Reference dependence and incremental WTP. ESSEC Business School, Working paper 1609.
Lhuillery S, Lamiraud K (2016). The determinants of user innovation in medical imaging devices. DRUID conference, February 22-24th, 2016, Singapore, hal-01512886.
Abul Naga RH, Lamiraud K (2008). Catastrophic Health Expenditure and Household Well-Being. STICERD - Distributional Analysis Research Programme Papers 098, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE.
OTHER PUBLISHED PAPERS AND ABTRACTS
Browne J, Sørensen T, Bonati M, Edwards N, Gunning-Schepers L, Keil P, Lamiraud K, LangeP, Olauson A, Olsen J, Sans S, Sauer F, Scintee SG, Wysocki MJ (2013). Recommendations for accessing EU funding on public health research(Short Survey)[I finanziamenti UE su Ricerca in Salute Pubblica: Le raccomandazioni per accedere]. Ricerca e Pratica 29(4): 173-175.
Gossec L, Berenbaum F, Chauvin P, Lamiraud K, Russo-Marie F. Peurs et croyances des patients souffrant de polyarthrite rhumatoïde et de spondylarthrites: Une revue systématique de la littérature (2012). Rev Rhumatisme 79: A133-A334. Last updated: June 2026
Lamiraud K, Holly A, Wietlisbach V, Burnand B, Vader JP, Froehlich F, Gonvers JJ (2003). The effect of health care system and environment on variations in performance and quality of colonoscopy. Gastrointestinal Endoscopy 57 (5): AB111-AB111.
Lilliu H, Le Pen C, Lamiraud K, Wittenberg W (2003). A Cost-Effectiveness Analysis of ACE Inhibitor Trandolapril as a Preventative Treatment of Heart-Failure Progression. Value in Health 6 (6) : 631.
Lilliu H, Le Pen C, Lamiraud K, Wittenberg W (2003). A Cost and Cost-Effectiveness (CE) Analysis of Angiotensin Converting Enzyme (ACE) Inhibitor Trandolapril in the Treatment of Post Infarction in the US. Value in Health 6 (3) : 320-321.
DISSERTATION
An economic and econometric analysis of patient adherence behaviour: implementation on trial clinical data in HIV disease (in French) (2004). http://www.chuv.ch/bdfm/cdsp/TheseLamiraud.pdf